Gilead Sciences Amesh Adalja hospital covid-19 doctor infection Gilead Sciences Amesh Adalja

Experts raise questions about severity of Trump's Covid-19

Reading now: 597
www.livemint.com

that is being studied for early infections. On Saturday, the president was started on a five-day course of intravenous antiviral drug remdesivir, which is sold by Gilead Sciences .

If Trump no longer requires supplemental oxygen and is able to return to his normal activities, his doctors could discharge him from the hospital, said Dr.

Amesh Adalja, an infectious disease specialist at Johns Hopkins University.     "The biggest question would be is there a risk of deterioration, or is he on a good trajectory?" he said.

COVID-19 is often characterized as having two phases - the viral infection itself and in some cases an overreaction of the body's immune system that can cause organ damage.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA